Enhanced Osteogenesis by Combining Exogenous BMPs with Hydroxyapatite/Aragonite Bone Grafts: In Vitro and In Vivo Studies
Source abstract
Abstract
Synthetic biomaterials are widely used as bone graft substitutes, but their osteogenic capacity is limited as they lack osteogenic growth factors. This study aimed to enhance the osteogenesis of a novel hydroxyapatite/aragonite (HAA) biomaterial by incorporating decellularized bone matrix and bone morphogenetic protein (BMP)-2 and BMP-7 (BMP-2/7). Human umbilical mesenchymal stem cells (MSCs) were able to proliferate and differentiate on HAA. HEK-293T cells exogenously expressing BMP-2/7 successfully secreted BMP-2/7, which was assessed by enzyme-linked immunosorbent assay. By establishing a co-culture of MSCs with HEK-293T cells expressing BMP-2/7, we successfully created an artificial allograft that integrates both synthetic biomaterials and functional organic components, offering the potential to enhance osteogenesis. The decellularized (by freeze/thawing) functional HAA was implanted between the tibia and anterior tibialis muscle in murine models and assessed the induced bone formation via micro-computer tomography, histology, and osteogenic markers mRNA expression by a reverse transcription-quantitative polymerase chain reaction. A significant increase in new bone formation was seen in the functional HAA implanted group. In conclusion, this study revealed that bone formation following the HAA implantation can be enhanced by a functional decellularized matrix, comprising BMP-2/7, via in vitro tissue engineering using MSCs and HEK-293T cells expressing BMP-2/7.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Swansea University Medical School, Faculty of Medicine, Health and Life Science, Swansea University, Swansea SA2 8PP, UK
Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Funding
Québec–Wales Collaboration Grant 2021 · WEFO ERDF HTC Accelerator grant
References (60)
Show source-provided references
1. Limitations of Autograft and Allograft: New Synthetic Solutions
2. Bone allograft in the U.K.: Perceptions and realities10.5301/hipint.5000018 ↗
3. Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery10.1097/BOT.0000000000001420 ↗
4. Synthetic bone graft versus autograft or allograft for spinal fusion: A systematic review10.3171/2016.1.SPINE151005 ↗
5. Three-dimensional biofabrication of an aragonite-enriched self-hardening bone graft substitute and assessment of its osteogenicity in vitro and in vivo
6. Ielo, I., Calabrese, G., De Luca, G., and Conoci, S. (2022). Recent Advances in Hydroxyapatite-Based Biocomposites for Bone Tissue Regeneration in Orthopedics. Int. J. Mol. Sci., 23.10.3390/ijms23179721 ↗
7. Bone biomaterials and interactions with stem cells10.1038/boneres.2017.59 ↗
8. Adhesion and Proliferation of Osteoblastic Cells on Hydroxyapatite-dispersed Ti-based Composite Plate10.21873/invivo.11575 ↗
9. Degradation pattern of porous CaCO3 and hydroxyapatite microspheres in vitro and in vivo for potential application in bone tissue engineering10.1016/j.colsurfb.2016.03.020 ↗
10. Transfection systems for Babesia bovis: A review of methods for the transient and stable expression of exogenous genes10.1016/j.vetpar.2009.09.022 ↗
11. Differential Roles for Bone Morphogenetic Protein (BMP) Receptor Type IB and IA in Differentiation and Specification of Mesenchymal Precursor Cells to Osteoblast and Adipocyte Lineages10.1083/jcb.142.1.295 ↗
12. Regulated Production of a Peroxisome Proliferator-activated Receptor-γ Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes*10.1074/jbc.M405346200 ↗
13. Regulation of bone and cartilage development by network between BMP signalling and transcription factors10.1093/jb/mvs004 ↗
14. McDonald, N.M., Woodell-May, J.E., and Pietrzak, W.S. (2005, January 20–23). Bone morphogenetic protein concentration in human demineralized bone matrix. Proceedings of the 51st Annual Meeting of the Orthopaedic Research Society, Washington, DC, USA. Available online: https://www.google.com.hk/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.ors.org/transactions/51/1659.pdf&ved=2ahUKEwi7xojD1s-PAxV-yDgGHZ15HvcQFnoECCAQAQ&usg=AOvVaw2lJwV8LUqICs23Sq-S9py4.
15. Manufacturing artificial bone allografts: A perspective
16. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis10.3171/2014.10.SPINE14338 ↗
17. Controlled dual delivery of low doses of BMP-2 and VEGF in a silk fibroin–nanohydroxyapatite scaffold for vascularized bone regeneration10.1039/C7TB00949F ↗
18. BMP gene delivery for skeletal tissue regeneration10.1016/j.bone.2020.115449 ↗
19. Rapid assessment of the osteogenic capacity of hydroxyapatite/aragonite using a murine tibial periosteal ossification model
20. Jannoo, R., Xia, Z., Row, P.E., and Kanamarlapudi, V. (2023). Targeting of the Interleukin-13 Receptor (IL-13R)alpha2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide. Biomolecules, 13.10.3390/biom13020356 ↗
21. Effects of freezing/thawing on the mechanical properties of decellularized lungs10.1002/jbm.a.34708 ↗
22. Decellularization of fibroblast cell sheets for natural extracellular matrix scaffold preparation10.1089/ten.tec.2013.0666 ↗
23. Freeze-Drying of Proteins10.1007/978-1-0716-0783-1_37 ↗
24. Lu, H. (2024). Enhanced Osteogenesis by Combining Exogenous BMPs with Hydroxyapatite/Calcium Carbonate Bone Grafts: In Vitro and In Vivo Study. [M.D. Thesis, Swansea University].
25. Kanamarlapudi, V., Tamaddon-Jahromi, S., and Murphy, K. (2022). ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it. PLoS ONE, 17.10.1371/journal.pone.0263845 ↗
26. An, Y.H., and Martin, K.L. (2003). Basic Staining and Histochemical Techniques and Immunohistochemical Localizations Using Bone Sections. Handbook of Histology Methods for Bone and Cartilage, Humana Press.
27. Development of BMP7-producing human cells, using a third generation lentiviral gene delivery system10.1016/j.jneumeth.2011.12.007 ↗
28. Expression, purification, bioactivity, and partial characterization of a recombinant human bone morphogenetic protein-7 produced in human 293T cells10.1007/s12033-010-9287-0 ↗
29. Allograft and bone morphogenetic proteins: An overview10.1016/S0020-1383(08)70013-5 ↗
30. New-bone formation by osteogenic protein-1 and autogenic bone marrow in a critical tibial defect model in sheep10.1055/s-2005-836800 ↗
31. In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector
32. Possibilities and efficiency of MSC co-transfection for gene therapy10.1186/s13287-024-03757-6 ↗
33. Nucleic acid delivery to mesenchymal stem cells: A review of nonviral methods and applications10.1186/s13036-019-0140-0 ↗
34. AB0063 High-efficiency transduction of mesenchymal stem cells by aav2/dj vector for their potential use in autoimmune diseases10.1136/annrheumdis-2018-eular.5014 ↗
35. Adeno-associated viral vector transduction of human mesenchymal stem cells10.22203/eCM.v013a10 ↗
36. Optimized Transgene Delivery Using Third-Generation Lentiviruses10.1002/cpmb.125 ↗
37. Tan, E., Chin, C.S.H., Lim, Z.F.S., and Ng, S.K. (2021). HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.796991 ↗
38. Molecular characterization of HEK293 cells as emerging versatile cell factories10.1016/j.copbio.2021.05.001 ↗
39. The Role of Osteobiologics in Spinal Deformity10.1016/j.nec.2007.01.002 ↗
40. Bone Graft Options in Spinal Fusion: A Review of Current Options and the Use of Mesenchymal Cellular Bone Matrices10.1016/j.wneu.2021.11.130 ↗
41. Errico, T.J., Lonner, B.S., and Moulton, A.W. (2009). CHAPTER 27—Bone Graft and Fusion Enhancement. Surgical Management of Spinal Deformities, W.B. Saunders.
42. Lao, T., Avalos, I., Rodríguez, E.M., Zamora, Y., Rodriguez, A., Ramón, A., Alvarez, Y., Cabrales, A., Andújar, I., and González, L.J. (2023). Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19. PLoS ONE, 18.10.1371/journal.pone.0288006 ↗
43. Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework10.1016/j.vaccine.2019.08.018 ↗
44. Bone mineral: New insights into its chemical composition10.1038/s41598-019-44620-6 ↗
45. Amini, Z., and Lari, R. (2021). A systematic review of decellularized allograft and xenograft-derived scaffolds in bone tissue regeneration. Tissue Cell, 69.10.1016/j.tice.2021.101494 ↗
46. Cost-effectiveness of decellularised bone allograft compared with fresh-frozen bone allograft for acetabular impaction bone grafting during a revision hip arthroplasty in the UK10.1136/bmjopen-2022-067876 ↗
47. An overview of decellularisation techniques of native tissues and tissue engineered products for bone, ligament and tendon regeneration10.1016/j.ymeth.2019.08.002 ↗
48. Fisher, J.N., Peretti, G.M., and Scotti, C. (2016). Stem Cells for Bone Regeneration: From Cell-Based Therapies to Decellularised Engineered Extracellular Matrices. Stem Cells Int., 2016.10.1155/2016/9352598 ↗
49. The biomimetic extracellular matrix: A therapeutic tool for breast cancer research10.1016/j.trsl.2021.11.008 ↗
50. Optimizing Decellularization of Bovine Ovarian Tissue: Toward a Transplantable Artificial Ovary Scaffold with Minimized Residual Toxicity and Preserved Extracellular Matrix Morphology10.1159/000537838 ↗
51. The biology of fracture healing10.1016/j.injury.2011.03.031 ↗
52. Bone development10.1016/j.bone.2015.04.035 ↗
53. CD169(+) macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair10.1016/j.biomaterials.2017.10.033 ↗
54. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin10.1038/s41467-018-03124-z ↗
55. Uncovering the periosteum for skeletal regeneration: The stem cell that lies beneath10.1016/j.bone.2014.08.007 ↗
56. Soluble expression and purification of high-bioactivity recombinant human bone morphogenetic protein-2 by codon optimisation in Escherichia coli10.1093/protein/gzz028 ↗
57. 3D Printed Integrated Bionic Oxygenated Scaffold for Bone Regeneration10.1021/acsami.2c04378 ↗
58. Design of Porous Micro-Structures Using Curvature Analysis for Additive-Manufacturing10.1016/j.procir.2015.01.057 ↗
59. Zhang, X.-Y., Yan, X.-C., Fang, G., and Liu, M. (2020). Biomechanical influence of structural variation strategies on functionally graded scaffolds constructed with triply periodic minimal surface. Addit. Manuf., 32.10.1016/j.addma.2019.101015 ↗
60. The bio-compatible dental implant designed by using non-stochastic porosity produced by Electron Beam Melting® (EBM)10.1016/j.jmatprotec.2014.02.025 ↗